Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468286
Status:
COMPLETED
Last Update Posted:
2011-03-23
First Post:
2007-04-13
Brief Title:
Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-13
First Submit QC Date:
May 1 2007
Study First Post Date:
2007-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-03-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-07-02
Disp First Submit QC Date:
October 1 2009
Disp First Post Date:
2009-10-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-03-21
Last Update Post Date:
2011-03-23
Last Update Post Date Type:
ESTIMATED